SRF and invasive breast carcinoma: To determine if CRP2 interacts with SRF in invasive breast cancer cells, CRP2-GFP was expressed in MDA-MB-231 cells and immunoprecipitated using GFP-Trap, and the pull-down was probed with an anti-SRF antibody.